• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向淋巴管生成以预防肿瘤转移。

Targeting lymphangiogenesis to prevent tumour metastasis.

作者信息

Achen M G, Mann G B, Stacker S A

机构信息

Ludwig Institute for Cancer Research, Post Office Box 2008 Royal Melbourne Hospital, Victoria 3050, Australia.

出版信息

Br J Cancer. 2006 May 22;94(10):1355-60. doi: 10.1038/sj.bjc.6603120.

DOI:10.1038/sj.bjc.6603120
PMID:16641900
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2361285/
Abstract

Recent studies involving animal models of cancer and clinicopathological analyses of human tumours suggest that the growth of lymphatic vessels (lymphangiogenesis) in or nearby tumours is associated with the metastatic spread of cancer. The best validated molecular signalling system for tumour lymphangiogenesis involves the secreted proteins vascular endothelial growth factor-C (VEGF-C) and VEGF-D that induce growth of lymphatic vessels via activation of VEGF receptor-3 (VEGFR-3) localised on the surface of lymphatic endothelial cells. In this review, we discuss the evidence supporting a role for this signalling system in the spread of cancer and potential approaches for blocking this system to prevent tumour metastasis.

摘要

近期涉及癌症动物模型及人类肿瘤临床病理分析的研究表明,肿瘤内部或附近淋巴管的生长(淋巴管生成)与癌症的转移扩散相关。对于肿瘤淋巴管生成,最具验证性的分子信号系统涉及分泌蛋白血管内皮生长因子C(VEGF-C)和血管内皮生长因子D(VEGF-D),它们通过激活位于淋巴管内皮细胞表面的血管内皮生长因子受体3(VEGFR-3)来诱导淋巴管生长。在本综述中,我们讨论了支持该信号系统在癌症扩散中发挥作用的证据,以及阻断该系统以预防肿瘤转移的潜在方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efda/2361285/3a8392f2b848/94-6603120f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efda/2361285/3a8392f2b848/94-6603120f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efda/2361285/3a8392f2b848/94-6603120f1.jpg

相似文献

1
Targeting lymphangiogenesis to prevent tumour metastasis.靶向淋巴管生成以预防肿瘤转移。
Br J Cancer. 2006 May 22;94(10):1355-60. doi: 10.1038/sj.bjc.6603120.
2
Role of lymphangiogenic factors in tumor metastasis.淋巴管生成因子在肿瘤转移中的作用。
Biochim Biophys Acta. 2004 Mar 4;1654(1):3-12. doi: 10.1016/j.bbcan.2003.07.003.
3
Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3.舒尼替尼通过抑制血管内皮生长因子受体 3 抑制乳腺癌模型中的淋巴管内皮细胞功能和淋巴结转移。
Breast Cancer Res. 2011 Jun 21;13(3):R66. doi: 10.1186/bcr2903.
4
Molecular mechanisms of lymphangiogenesis.淋巴管生成的分子机制
Int J Hematol. 2004 Jul;80(1):29-34. doi: 10.1532/ijh97.04042.
5
Molecular control of lymphatic metastasis.淋巴转移的分子调控
Ann N Y Acad Sci. 2008;1131:225-34. doi: 10.1196/annals.1413.020.
6
Tumor-induced lymphangiogenesis: a target for cancer therapy?肿瘤诱导的淋巴管生成:癌症治疗的一个靶点?
J Biotechnol. 2006 Jun 25;124(1):224-41. doi: 10.1016/j.jbiotec.2006.01.007. Epub 2006 Feb 23.
7
Signaling for lymphangiogenesis via VEGFR-3 is required for the early events of metastasis.通过 VEGFR-3 信号转导促进淋巴管生成是转移早期事件所必需的。
Clin Exp Metastasis. 2013 Aug;30(6):819-32. doi: 10.1007/s10585-013-9581-x. Epub 2013 Apr 17.
8
Molecular targeting of lymphatics for therapy.用于治疗的淋巴管分子靶向
Curr Pharm Des. 2004;10(1):65-74. doi: 10.2174/1381612043453513.
9
[Molecular mechanisms of lymphatic development].[淋巴系统发育的分子机制]
Seikagaku. 2004 Sep;76(9):1210-6.
10
Liposomal honokiol inhibits VEGF-D-induced lymphangiogenesis and metastasis in xenograft tumor model.脂质体厚朴酚抑制异种移植肿瘤模型中VEGF-D诱导的淋巴管生成和转移。
Int J Cancer. 2009 Jun 1;124(11):2709-18. doi: 10.1002/ijc.24244.

引用本文的文献

1
Towards an emerging role for anticoagulants in cancer therapy: a systematic review and meta-analysis.抗凝剂在癌症治疗中新兴作用的系统评价与荟萃分析
Front Oral Health. 2024 Nov 6;5:1495942. doi: 10.3389/froh.2024.1495942. eCollection 2024.
2
The global landscape and research trend of lymphangiogenesis in breast cancer: a bibliometric analysis and visualization.乳腺癌淋巴管生成的全球格局与研究趋势:文献计量分析与可视化
Front Oncol. 2024 Mar 14;14:1337124. doi: 10.3389/fonc.2024.1337124. eCollection 2024.
3
Targeting Tumor Angiogenesis with the Selective VEGFR-3 Inhibitor EVT801 in Combination with Cancer Immunotherapy.

本文引用的文献

1
Importance of lymph vessels in gastric cancer: a prognostic indicator in general and a predictor for lymph node metastasis in early stage cancer.淋巴管在胃癌中的重要性:一般作为预后指标及早期癌症淋巴结转移的预测指标。
J Clin Pathol. 2006 Jan;59(1):77-82. doi: 10.1136/jcp.2005.028779.
2
Vascular endothelial growth factor-D and its receptor VEGFR-3: two novel independent prognostic markers in gastric adenocarcinoma.血管内皮生长因子-D及其受体VEGFR-3:胃腺癌中两个新的独立预后标志物。
J Clin Oncol. 2006 Jan 10;24(2):228-40. doi: 10.1200/JCO.2004.00.3467. Epub 2005 Dec 12.
3
Peritumoral lymphatic vessel density and vascular endothelial growth factor C expression in early-stage squamous cell carcinoma of the uterine cervix.
针对肿瘤血管生成的选择性 VEGFR-3 抑制剂 EVT801 与癌症免疫疗法联合应用。
Cancer Res Commun. 2022 Nov 29;2(11):1504-1519. doi: 10.1158/2767-9764.CRC-22-0151. eCollection 2022 Nov.
4
Lymphatic immunomodulation using engineered drug delivery systems for cancer immunotherapy.利用工程化药物传递系统进行淋巴免疫调节以用于癌症免疫治疗。
Adv Drug Deliv Rev. 2020;160:19-35. doi: 10.1016/j.addr.2020.10.004. Epub 2020 Oct 12.
5
Neuropilin-2b facilitates resistance to tyrosine kinase inhibitors in non-small cell lung cancer.神经纤毛蛋白-2b 促进非小细胞肺癌对酪氨酸激酶抑制剂的耐药性。
J Thorac Cardiovasc Surg. 2021 Aug;162(2):463-473. doi: 10.1016/j.jtcvs.2020.03.166. Epub 2020 May 25.
6
Soluble Vegfr3 gene therapy suppresses multi-organ metastasis in a mouse mammary cancer model.可溶性 Vegfr3 基因治疗抑制小鼠乳腺癌模型多器官转移。
Cancer Sci. 2020 Aug;111(8):2837-2849. doi: 10.1111/cas.14531. Epub 2020 Jul 4.
7
The anti-cancer properties of heparin and its derivatives: a review and prospect.肝素及其衍生物的抗癌特性:综述与展望。
Cell Adh Migr. 2020 Dec;14(1):118-128. doi: 10.1080/19336918.2020.1767489.
8
Effect of VEGFC on lymph flow and inflammation-induced alveolar bone loss.VEGFC 对淋巴液流动和炎症诱导的牙槽骨丧失的影响。
J Pathol. 2020 Jul;251(3):323-335. doi: 10.1002/path.5456. Epub 2020 Jun 10.
9
CXCL11-CXCR3 Axis Mediates Tumor Lymphatic Cross Talk and Inflammation-Induced Tumor, Promoting Pathways in Head and Neck Cancers.CXCL11-CXCR3 轴介导肿瘤淋巴管相互作用和炎症诱导的肿瘤促进途径在头颈部癌症中的作用。
Am J Pathol. 2020 Apr;190(4):900-915. doi: 10.1016/j.ajpath.2019.12.004. Epub 2020 Feb 5.
10
Communication Of Cancer Cells And Lymphatic Vessels In Cancer: Focus On Bladder Cancer.癌症中癌细胞与淋巴管的通讯:聚焦膀胱癌
Onco Targets Ther. 2019 Oct 3;12:8161-8177. doi: 10.2147/OTT.S219111. eCollection 2019.
宫颈早期鳞状细胞癌瘤周淋巴管密度及血管内皮生长因子C表达
Clin Cancer Res. 2005 Dec 1;11(23):8364-71. doi: 10.1158/1078-0432.CCR-05-1238.
4
Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis.肿瘤分泌的血管内皮生长因子-C对前列腺癌淋巴管生成是必需的,但淋巴管生成对淋巴结转移并非必需。
Cancer Res. 2005 Nov 1;65(21):9789-98. doi: 10.1158/0008-5472.CAN-05-0901.
5
Lymphangiogenesis correlates with lymph node metastasis, prognosis, and angiogenic phenotype in human non-small cell lung cancer.淋巴管生成与人类非小细胞肺癌中的淋巴结转移、预后及血管生成表型相关。
Clin Cancer Res. 2005 Oct 15;11(20):7344-53. doi: 10.1158/1078-0432.CCR-05-1077.
6
Down-regulation of vascular endothelial cell growth factor-C expression using small interfering RNA vectors in mammary tumors inhibits tumor lymphangiogenesis and spontaneous metastasis and enhances survival.使用小干扰RNA载体下调乳腺肿瘤中血管内皮细胞生长因子-C的表达可抑制肿瘤淋巴管生成和自发性转移并提高生存率。
Cancer Res. 2005 Oct 1;65(19):9004-11. doi: 10.1158/0008-5472.CAN-05-0885.
7
Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer.血管内皮生长因子-D在胰腺导管癌模型中诱导淋巴管生成和淋巴转移。
Int J Oncol. 2005 Sep;27(3):669-79.
8
Inhibition of lymphogenous metastasis using adeno-associated virus-mediated gene transfer of a soluble VEGFR-3 decoy receptor.利用腺相关病毒介导的可溶性血管内皮生长因子受体-3诱饵受体基因转移抑制淋巴源性转移
Cancer Res. 2005 Aug 1;65(15):6901-9. doi: 10.1158/0008-5472.CAN-05-0408.
9
Regulation of the stepwise proteolytic cleavage and secretion of PDGF-B by the proprotein convertases.前蛋白转化酶对血小板衍生生长因子-B(PDGF-B)逐步进行蛋白水解切割及分泌的调控。
Oncogene. 2005 Oct 20;24(46):6925-35. doi: 10.1038/sj.onc.1208838.
10
Enzyme histochemical analysis of lymphatic vessels in colon carcinoma: occurrence of lymphangiogenesis within the tumor.结肠癌中淋巴管的酶组织化学分析:肿瘤内淋巴管生成的发生情况
Hepatogastroenterology. 2005 Jul-Aug;52(64):1057-61.